AerSale
ASLE · NASDAQ
About ASLE
- Employees
- 704
- Headquarters
- Doral, Florida
- Listed
- Feb 28, 2019
- Sector
- Industrials
- Industry
- Aerospace & Defense
- Website
- aersale.com
ASLE key statistics
- Market cap
- 227.18M
- Price-earnings ratio
- 26.44
- Dividend yield
- —
- Average volume
- 469.90K
- Volume
- 286.06K
- Open price
- $4.78
- High today
- $4.79
- Low today
- $4.64
- 52 Week high
- $8.04
- 52 Week low
- $4.66
AerSale (ASLE) at a glance
AerSale (ASLE) last traded at $4.68, with a market cap of 227.18M and a price-to-earnings ratio of 26.44.
Today the stock has traded between $4.64 and $4.79. The current price is 1.0% above the day's low and 2.3% below its high.
Volume so far is 286.06K shares, below the average of 469.90K shares a day.
Over the past year AerSale has ranged from $4.66 to $8.04, and now sits 1% of the way up that range.
AerSale met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY26 it reported -$0.09 per share against an estimate of $0.1377.
The average analyst price target is $7.39, 58.0% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy0.0%
- Hold100.0%
- Sell0.0%
- Low
- $7.07
- Now
- $4.68
- High
- $7.88
ASLE earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 1 of the last 8 quarters, by 553.6% on average.
- Q3 FY24: reported $0.04 per share against an estimate of $0.0544
- Q4 FY24: reported $0.09 per share against an estimate of $0.0918
- Q1 FY25: reported -$0.05 per share against an estimate of $0.0867
- Q2 FY25: reported $0.20 per share against an estimate of $0.0306
- Q3 FY25: reported $0.04 per share against an estimate of $0.1617
- Q4 FY25: reported $0.16 per share against an estimate of $0.1989
- Q1 FY26: reported $0.00 per share against an estimate of $0.0255
- Q2 FY26: reported -$0.09 per share against an estimate of $0.1377
ASLE news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
AerSale® Announces Date for Second Quarter 2026 Earnings Release Conference Call
- Press releaseGlobe Newswire
AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit
12 Industrials Stocks Moving In Thursday's After-Market Session
- Press releaseGlobe Newswire
AerSale Reports First Quarter 2026 Results
- Press releaseGlobe Newswire
AerSale® Announces Date for First Quarter 2026 Earnings Release Conference Call
- Press releaseGlobe Newswire
AerSale® Reports Fourth Quarter and Full Year 2025 Results
- Press releaseGlobe Newswire
AerSale® Announces Date for Fourth Quarter and Full Year 2025 Earnings Release Conference Call
Similar companies
Companies in the same industry as AerSale
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- FRTTFort Technology$0.7121+32.63%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.